Background Multiple long-term conditions (MLTCs) are common among individuals with heart failure (HF); however, the influence ...
All in all, PHAT has 6 recent analyst reviews that break down into 5 Buys and 1 Hold, giving the stock a Strong Buy consensus rating. The shares are priced at $17.66 and have an average price target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback